st 1059 has been researched along with etilefrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berlin, E; Gjöres, JE; Thulesius, O | 1 |
| Pittner, H | 1 |
2 other study(ies) available for st 1059 and etilefrine
| Article | Year |
|---|---|
Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins.
Topics: Dihydroergotamine; Ethanolamines; Etilefrine; Humans; In Vitro Techniques; Midodrine; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Vasoconstrictor Agents; Veins | 1979 |
Vasoconstrictor effects of midodrine, ST 1059, noradrenaline, etilefrine and norfenefrine on isolated dog femoral arteries and veins.
Topics: 2-Hydroxyphenethylamine; Adrenergic alpha-Agonists; Animals; Dogs; Etilefrine; Femoral Artery; Femoral Vein; In Vitro Techniques; Midodrine; Muscle, Smooth, Vascular; Norepinephrine; Octopamine; Vasoconstrictor Agents | 1983 |